Global Disease Control and Prevention Vaccine Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Vaccines are biological entity used to activate acquired immunity to control or prevent particular disease or a group of disease. Immunization is carried out in infants as well as in adults. Vaccination against various bacterial and viral diseases is an integral part of infectious disease control world-wide.
LPI (LP Information)' newest research report, the “Disease Control and Prevention Vaccine Industry Forecast” looks at past sales and reviews total world Disease Control and Prevention Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Disease Control and Prevention Vaccine sales for 2023 through 2029. With Disease Control and Prevention Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Disease Control and Prevention Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Disease Control and Prevention Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Disease Control and Prevention Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Disease Control and Prevention Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Disease Control and Prevention Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Disease Control and Prevention Vaccine.
The global Disease Control and Prevention Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Disease Control and Prevention Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Disease Control and Prevention Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Disease Control and Prevention Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Disease Control and Prevention Vaccine players cover GSK, Merck & Co., Inc, Pfizer, Sanofi, AstraZeneca PLC, Sinovac Biotech Ltd, Astellas Pharma Inc, Serum Institute of India Pvt. Ltd and Daiichi Sankyo, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Disease Control and Prevention Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Disease Control and Prevention Vaccine market?
What factors are driving Disease Control and Prevention Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Disease Control and Prevention Vaccine market opportunities vary by end market size?
How does Disease Control and Prevention Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Vaccines are biological entity used to activate acquired immunity to control or prevent particular disease or a group of disease. Immunization is carried out in infants as well as in adults. Vaccination against various bacterial and viral diseases is an integral part of infectious disease control world-wide.
LPI (LP Information)' newest research report, the “Disease Control and Prevention Vaccine Industry Forecast” looks at past sales and reviews total world Disease Control and Prevention Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Disease Control and Prevention Vaccine sales for 2023 through 2029. With Disease Control and Prevention Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Disease Control and Prevention Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Disease Control and Prevention Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Disease Control and Prevention Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Disease Control and Prevention Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Disease Control and Prevention Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Disease Control and Prevention Vaccine.
The global Disease Control and Prevention Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Disease Control and Prevention Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Disease Control and Prevention Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Disease Control and Prevention Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Disease Control and Prevention Vaccine players cover GSK, Merck & Co., Inc, Pfizer, Sanofi, AstraZeneca PLC, Sinovac Biotech Ltd, Astellas Pharma Inc, Serum Institute of India Pvt. Ltd and Daiichi Sankyo, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Disease Control and Prevention Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Live-Attenuated
- Inactivated
- Recombinant Sub Unit and Toxoid
- Pediatric Vaccine
- Adult Vaccine
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GSK
- Merck & Co., Inc
- Pfizer
- Sanofi
- AstraZeneca PLC
- Sinovac Biotech Ltd
- Astellas Pharma Inc
- Serum Institute of India Pvt. Ltd
- Daiichi Sankyo
What is the 10-year outlook for the global Disease Control and Prevention Vaccine market?
What factors are driving Disease Control and Prevention Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Disease Control and Prevention Vaccine market opportunities vary by end market size?
How does Disease Control and Prevention Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Disease Control and Prevention Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Disease Control and Prevention Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Disease Control and Prevention Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Disease Control and Prevention Vaccine Segment by Type
2.2.1 Live-Attenuated
2.2.2 Inactivated
2.2.3 Recombinant Sub Unit and Toxoid
2.3 Disease Control and Prevention Vaccine Sales by Type
2.3.1 Global Disease Control and Prevention Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Disease Control and Prevention Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Disease Control and Prevention Vaccine Sale Price by Type (2018-2023)
2.4 Disease Control and Prevention Vaccine Segment by Application
2.4.1 Pediatric Vaccine
2.4.2 Adult Vaccine
2.5 Disease Control and Prevention Vaccine Sales by Application
2.5.1 Global Disease Control and Prevention Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Disease Control and Prevention Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Disease Control and Prevention Vaccine Sale Price by Application (2018-2023)
3 GLOBAL DISEASE CONTROL AND PREVENTION VACCINE BY COMPANY
3.1 Global Disease Control and Prevention Vaccine Breakdown Data by Company
3.1.1 Global Disease Control and Prevention Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Disease Control and Prevention Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Disease Control and Prevention Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Disease Control and Prevention Vaccine Revenue by Company (2018-2023)
3.2.2 Global Disease Control and Prevention Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Disease Control and Prevention Vaccine Sale Price by Company
3.4 Key Manufacturers Disease Control and Prevention Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Disease Control and Prevention Vaccine Product Location Distribution
3.4.2 Players Disease Control and Prevention Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR DISEASE CONTROL AND PREVENTION VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Disease Control and Prevention Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Disease Control and Prevention Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Disease Control and Prevention Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Disease Control and Prevention Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Disease Control and Prevention Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Disease Control and Prevention Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Disease Control and Prevention Vaccine Sales Growth
4.4 APAC Disease Control and Prevention Vaccine Sales Growth
4.5 Europe Disease Control and Prevention Vaccine Sales Growth
4.6 Middle East & Africa Disease Control and Prevention Vaccine Sales Growth
5 AMERICAS
5.1 Americas Disease Control and Prevention Vaccine Sales by Country
5.1.1 Americas Disease Control and Prevention Vaccine Sales by Country (2018-2023)
5.1.2 Americas Disease Control and Prevention Vaccine Revenue by Country (2018-2023)
5.2 Americas Disease Control and Prevention Vaccine Sales by Type
5.3 Americas Disease Control and Prevention Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Disease Control and Prevention Vaccine Sales by Region
6.1.1 APAC Disease Control and Prevention Vaccine Sales by Region (2018-2023)
6.1.2 APAC Disease Control and Prevention Vaccine Revenue by Region (2018-2023)
6.2 APAC Disease Control and Prevention Vaccine Sales by Type
6.3 APAC Disease Control and Prevention Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Disease Control and Prevention Vaccine by Country
7.1.1 Europe Disease Control and Prevention Vaccine Sales by Country (2018-2023)
7.1.2 Europe Disease Control and Prevention Vaccine Revenue by Country (2018-2023)
7.2 Europe Disease Control and Prevention Vaccine Sales by Type
7.3 Europe Disease Control and Prevention Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Disease Control and Prevention Vaccine by Country
8.1.1 Middle East & Africa Disease Control and Prevention Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Disease Control and Prevention Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Disease Control and Prevention Vaccine Sales by Type
8.3 Middle East & Africa Disease Control and Prevention Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Disease Control and Prevention Vaccine
10.3 Manufacturing Process Analysis of Disease Control and Prevention Vaccine
10.4 Industry Chain Structure of Disease Control and Prevention Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Disease Control and Prevention Vaccine Distributors
11.3 Disease Control and Prevention Vaccine Customer
12 WORLD FORECAST REVIEW FOR DISEASE CONTROL AND PREVENTION VACCINE BY GEOGRAPHIC REGION
12.1 Global Disease Control and Prevention Vaccine Market Size Forecast by Region
12.1.1 Global Disease Control and Prevention Vaccine Forecast by Region (2024-2029)
12.1.2 Global Disease Control and Prevention Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Disease Control and Prevention Vaccine Forecast by Type
12.7 Global Disease Control and Prevention Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Disease Control and Prevention Vaccine Product Portfolios and Specifications
13.1.3 GSK Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Merck & Co., Inc
13.2.1 Merck & Co., Inc Company Information
13.2.2 Merck & Co., Inc Disease Control and Prevention Vaccine Product Portfolios and Specifications
13.2.3 Merck & Co., Inc Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck & Co., Inc Main Business Overview
13.2.5 Merck & Co., Inc Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Disease Control and Prevention Vaccine Product Portfolios and Specifications
13.3.3 Pfizer Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Sanofi
13.4.1 Sanofi Company Information
13.4.2 Sanofi Disease Control and Prevention Vaccine Product Portfolios and Specifications
13.4.3 Sanofi Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sanofi Main Business Overview
13.4.5 Sanofi Latest Developments
13.5 AstraZeneca PLC
13.5.1 AstraZeneca PLC Company Information
13.5.2 AstraZeneca PLC Disease Control and Prevention Vaccine Product Portfolios and Specifications
13.5.3 AstraZeneca PLC Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 AstraZeneca PLC Main Business Overview
13.5.5 AstraZeneca PLC Latest Developments
13.6 Sinovac Biotech Ltd
13.6.1 Sinovac Biotech Ltd Company Information
13.6.2 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product Portfolios and Specifications
13.6.3 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Sinovac Biotech Ltd Main Business Overview
13.6.5 Sinovac Biotech Ltd Latest Developments
13.7 Astellas Pharma Inc
13.7.1 Astellas Pharma Inc Company Information
13.7.2 Astellas Pharma Inc Disease Control and Prevention Vaccine Product Portfolios and Specifications
13.7.3 Astellas Pharma Inc Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Astellas Pharma Inc Main Business Overview
13.7.5 Astellas Pharma Inc Latest Developments
13.8 Serum Institute of India Pvt. Ltd
13.8.1 Serum Institute of India Pvt. Ltd Company Information
13.8.2 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product Portfolios and Specifications
13.8.3 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Serum Institute of India Pvt. Ltd Main Business Overview
13.8.5 Serum Institute of India Pvt. Ltd Latest Developments
13.9 Daiichi Sankyo
13.9.1 Daiichi Sankyo Company Information
13.9.2 Daiichi Sankyo Disease Control and Prevention Vaccine Product Portfolios and Specifications
13.9.3 Daiichi Sankyo Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Daiichi Sankyo Main Business Overview
13.9.5 Daiichi Sankyo Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Disease Control and Prevention Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Disease Control and Prevention Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Disease Control and Prevention Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Disease Control and Prevention Vaccine Segment by Type
2.2.1 Live-Attenuated
2.2.2 Inactivated
2.2.3 Recombinant Sub Unit and Toxoid
2.3 Disease Control and Prevention Vaccine Sales by Type
2.3.1 Global Disease Control and Prevention Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Disease Control and Prevention Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Disease Control and Prevention Vaccine Sale Price by Type (2018-2023)
2.4 Disease Control and Prevention Vaccine Segment by Application
2.4.1 Pediatric Vaccine
2.4.2 Adult Vaccine
2.5 Disease Control and Prevention Vaccine Sales by Application
2.5.1 Global Disease Control and Prevention Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Disease Control and Prevention Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Disease Control and Prevention Vaccine Sale Price by Application (2018-2023)
3 GLOBAL DISEASE CONTROL AND PREVENTION VACCINE BY COMPANY
3.1 Global Disease Control and Prevention Vaccine Breakdown Data by Company
3.1.1 Global Disease Control and Prevention Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Disease Control and Prevention Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Disease Control and Prevention Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Disease Control and Prevention Vaccine Revenue by Company (2018-2023)
3.2.2 Global Disease Control and Prevention Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Disease Control and Prevention Vaccine Sale Price by Company
3.4 Key Manufacturers Disease Control and Prevention Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Disease Control and Prevention Vaccine Product Location Distribution
3.4.2 Players Disease Control and Prevention Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR DISEASE CONTROL AND PREVENTION VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Disease Control and Prevention Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Disease Control and Prevention Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Disease Control and Prevention Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Disease Control and Prevention Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Disease Control and Prevention Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Disease Control and Prevention Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Disease Control and Prevention Vaccine Sales Growth
4.4 APAC Disease Control and Prevention Vaccine Sales Growth
4.5 Europe Disease Control and Prevention Vaccine Sales Growth
4.6 Middle East & Africa Disease Control and Prevention Vaccine Sales Growth
5 AMERICAS
5.1 Americas Disease Control and Prevention Vaccine Sales by Country
5.1.1 Americas Disease Control and Prevention Vaccine Sales by Country (2018-2023)
5.1.2 Americas Disease Control and Prevention Vaccine Revenue by Country (2018-2023)
5.2 Americas Disease Control and Prevention Vaccine Sales by Type
5.3 Americas Disease Control and Prevention Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Disease Control and Prevention Vaccine Sales by Region
6.1.1 APAC Disease Control and Prevention Vaccine Sales by Region (2018-2023)
6.1.2 APAC Disease Control and Prevention Vaccine Revenue by Region (2018-2023)
6.2 APAC Disease Control and Prevention Vaccine Sales by Type
6.3 APAC Disease Control and Prevention Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Disease Control and Prevention Vaccine by Country
7.1.1 Europe Disease Control and Prevention Vaccine Sales by Country (2018-2023)
7.1.2 Europe Disease Control and Prevention Vaccine Revenue by Country (2018-2023)
7.2 Europe Disease Control and Prevention Vaccine Sales by Type
7.3 Europe Disease Control and Prevention Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Disease Control and Prevention Vaccine by Country
8.1.1 Middle East & Africa Disease Control and Prevention Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Disease Control and Prevention Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Disease Control and Prevention Vaccine Sales by Type
8.3 Middle East & Africa Disease Control and Prevention Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Disease Control and Prevention Vaccine
10.3 Manufacturing Process Analysis of Disease Control and Prevention Vaccine
10.4 Industry Chain Structure of Disease Control and Prevention Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Disease Control and Prevention Vaccine Distributors
11.3 Disease Control and Prevention Vaccine Customer
12 WORLD FORECAST REVIEW FOR DISEASE CONTROL AND PREVENTION VACCINE BY GEOGRAPHIC REGION
12.1 Global Disease Control and Prevention Vaccine Market Size Forecast by Region
12.1.1 Global Disease Control and Prevention Vaccine Forecast by Region (2024-2029)
12.1.2 Global Disease Control and Prevention Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Disease Control and Prevention Vaccine Forecast by Type
12.7 Global Disease Control and Prevention Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Disease Control and Prevention Vaccine Product Portfolios and Specifications
13.1.3 GSK Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Merck & Co., Inc
13.2.1 Merck & Co., Inc Company Information
13.2.2 Merck & Co., Inc Disease Control and Prevention Vaccine Product Portfolios and Specifications
13.2.3 Merck & Co., Inc Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck & Co., Inc Main Business Overview
13.2.5 Merck & Co., Inc Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Disease Control and Prevention Vaccine Product Portfolios and Specifications
13.3.3 Pfizer Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Sanofi
13.4.1 Sanofi Company Information
13.4.2 Sanofi Disease Control and Prevention Vaccine Product Portfolios and Specifications
13.4.3 Sanofi Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sanofi Main Business Overview
13.4.5 Sanofi Latest Developments
13.5 AstraZeneca PLC
13.5.1 AstraZeneca PLC Company Information
13.5.2 AstraZeneca PLC Disease Control and Prevention Vaccine Product Portfolios and Specifications
13.5.3 AstraZeneca PLC Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 AstraZeneca PLC Main Business Overview
13.5.5 AstraZeneca PLC Latest Developments
13.6 Sinovac Biotech Ltd
13.6.1 Sinovac Biotech Ltd Company Information
13.6.2 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product Portfolios and Specifications
13.6.3 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Sinovac Biotech Ltd Main Business Overview
13.6.5 Sinovac Biotech Ltd Latest Developments
13.7 Astellas Pharma Inc
13.7.1 Astellas Pharma Inc Company Information
13.7.2 Astellas Pharma Inc Disease Control and Prevention Vaccine Product Portfolios and Specifications
13.7.3 Astellas Pharma Inc Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Astellas Pharma Inc Main Business Overview
13.7.5 Astellas Pharma Inc Latest Developments
13.8 Serum Institute of India Pvt. Ltd
13.8.1 Serum Institute of India Pvt. Ltd Company Information
13.8.2 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product Portfolios and Specifications
13.8.3 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Serum Institute of India Pvt. Ltd Main Business Overview
13.8.5 Serum Institute of India Pvt. Ltd Latest Developments
13.9 Daiichi Sankyo
13.9.1 Daiichi Sankyo Company Information
13.9.2 Daiichi Sankyo Disease Control and Prevention Vaccine Product Portfolios and Specifications
13.9.3 Daiichi Sankyo Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Daiichi Sankyo Main Business Overview
13.9.5 Daiichi Sankyo Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Disease Control and Prevention Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Disease Control and Prevention Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Live-Attenuated
Table 4. Major Players of Inactivated
Table 5. Major Players of Recombinant Sub Unit and Toxoid
Table 6. Global Disease Control and Prevention Vaccine Sales by Type (2018-2023) & (K Units)
Table 7. Global Disease Control and Prevention Vaccine Sales Market Share by Type (2018-2023)
Table 8. Global Disease Control and Prevention Vaccine Revenue by Type (2018-2023) & ($ million)
Table 9. Global Disease Control and Prevention Vaccine Revenue Market Share by Type (2018-2023)
Table 10. Global Disease Control and Prevention Vaccine Sale Price by Type (2018-2023) & (USD/Unit)
Table 11. Global Disease Control and Prevention Vaccine Sales by Application (2018-2023) & (K Units)
Table 12. Global Disease Control and Prevention Vaccine Sales Market Share by Application (2018-2023)
Table 13. Global Disease Control and Prevention Vaccine Revenue by Application (2018-2023)
Table 14. Global Disease Control and Prevention Vaccine Revenue Market Share by Application (2018-2023)
Table 15. Global Disease Control and Prevention Vaccine Sale Price by Application (2018-2023) & (USD/Unit)
Table 16. Global Disease Control and Prevention Vaccine Sales by Company (2018-2023) & (K Units)
Table 17. Global Disease Control and Prevention Vaccine Sales Market Share by Company (2018-2023)
Table 18. Global Disease Control and Prevention Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Disease Control and Prevention Vaccine Revenue Market Share by Company (2018-2023)
Table 20. Global Disease Control and Prevention Vaccine Sale Price by Company (2018-2023) & (USD/Unit)
Table 21. Key Manufacturers Disease Control and Prevention Vaccine Producing Area Distribution and Sales Area
Table 22. Players Disease Control and Prevention Vaccine Products Offered
Table 23. Disease Control and Prevention Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Disease Control and Prevention Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Disease Control and Prevention Vaccine Sales Market Share Geographic Region (2018-2023)
Table 28. Global Disease Control and Prevention Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Disease Control and Prevention Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Disease Control and Prevention Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Disease Control and Prevention Vaccine Sales Market Share by Country/Region (2018-2023)
Table 32. Global Disease Control and Prevention Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Disease Control and Prevention Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Disease Control and Prevention Vaccine Sales by Country (2018-2023) & (K Units)
Table 35. Americas Disease Control and Prevention Vaccine Sales Market Share by Country (2018-2023)
Table 36. Americas Disease Control and Prevention Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Disease Control and Prevention Vaccine Revenue Market Share by Country (2018-2023)
Table 38. Americas Disease Control and Prevention Vaccine Sales by Type (2018-2023) & (K Units)
Table 39. Americas Disease Control and Prevention Vaccine Sales by Application (2018-2023) & (K Units)
Table 40. APAC Disease Control and Prevention Vaccine Sales by Region (2018-2023) & (K Units)
Table 41. APAC Disease Control and Prevention Vaccine Sales Market Share by Region (2018-2023)
Table 42. APAC Disease Control and Prevention Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Disease Control and Prevention Vaccine Revenue Market Share by Region (2018-2023)
Table 44. APAC Disease Control and Prevention Vaccine Sales by Type (2018-2023) & (K Units)
Table 45. APAC Disease Control and Prevention Vaccine Sales by Application (2018-2023) & (K Units)
Table 46. Europe Disease Control and Prevention Vaccine Sales by Country (2018-2023) & (K Units)
Table 47. Europe Disease Control and Prevention Vaccine Sales Market Share by Country (2018-2023)
Table 48. Europe Disease Control and Prevention Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Disease Control and Prevention Vaccine Revenue Market Share by Country (2018-2023)
Table 50. Europe Disease Control and Prevention Vaccine Sales by Type (2018-2023) & (K Units)
Table 51. Europe Disease Control and Prevention Vaccine Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Disease Control and Prevention Vaccine Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Disease Control and Prevention Vaccine Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Disease Control and Prevention Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Disease Control and Prevention Vaccine Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Disease Control and Prevention Vaccine Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Disease Control and Prevention Vaccine Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Disease Control and Prevention Vaccine
Table 59. Key Market Challenges & Risks of Disease Control and Prevention Vaccine
Table 60. Key Industry Trends of Disease Control and Prevention Vaccine
Table 61. Disease Control and Prevention Vaccine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Disease Control and Prevention Vaccine Distributors List
Table 64. Disease Control and Prevention Vaccine Customer List
Table 65. Global Disease Control and Prevention Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Disease Control and Prevention Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Disease Control and Prevention Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Disease Control and Prevention Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Disease Control and Prevention Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Disease Control and Prevention Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Disease Control and Prevention Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Disease Control and Prevention Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Disease Control and Prevention Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Disease Control and Prevention Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Disease Control and Prevention Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Disease Control and Prevention Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Disease Control and Prevention Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Disease Control and Prevention Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. GSK Basic Information, Disease Control and Prevention Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 80. GSK Disease Control and Prevention Vaccine Product Portfolios and Specifications
Table 81. GSK Disease Control and Prevention Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. GSK Main Business
Table 83. GSK Latest Developments
Table 84. Merck & Co., Inc Basic Information, Disease Control and Prevention Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 85. Merck & Co., Inc Disease Control and Prevention Vaccine Product Portfolios and Specifications
Table 86. Merck & Co., Inc Disease Control and Prevention Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Merck & Co., Inc Main Business
Table 88. Merck & Co., Inc Latest Developments
Table 89. Pfizer Basic Information, Disease Control and Prevention Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 90. Pfizer Disease Control and Prevention Vaccine Product Portfolios and Specifications
Table 91. Pfizer Disease Control and Prevention Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Pfizer Main Business
Table 93. Pfizer Latest Developments
Table 94. Sanofi Basic Information, Disease Control and Prevention Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 95. Sanofi Disease Control and Prevention Vaccine Product Portfolios and Specifications
Table 96. Sanofi Disease Control and Prevention Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Sanofi Main Business
Table 98. Sanofi Latest Developments
Table 99. AstraZeneca PLC Basic Information, Disease Control and Prevention Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 100. AstraZeneca PLC Disease Control and Prevention Vaccine Product Portfolios and Specifications
Table 101. AstraZeneca PLC Disease Control and Prevention Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. AstraZeneca PLC Main Business
Table 103. AstraZeneca PLC Latest Developments
Table 104. Sinovac Biotech Ltd Basic Information, Disease Control and Prevention Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 105. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product Portfolios and Specifications
Table 106. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. Sinovac Biotech Ltd Main Business
Table 108. Sinovac Biotech Ltd Latest Developments
Table 109. Astellas Pharma Inc Basic Information, Disease Control and Prevention Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 110. Astellas Pharma Inc Disease Control and Prevention Vaccine Product Portfolios and Specifications
Table 111. Astellas Pharma Inc Disease Control and Prevention Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. Astellas Pharma Inc Main Business
Table 113. Astellas Pharma Inc Latest Developments
Table 114. Serum Institute of India Pvt. Ltd Basic Information, Disease Control and Prevention Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 115. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product Portfolios and Specifications
Table 116. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. Serum Institute of India Pvt. Ltd Main Business
Table 118. Serum Institute of India Pvt. Ltd Latest Developments
Table 119. Daiichi Sankyo Basic Information, Disease Control and Prevention Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 120. Daiichi Sankyo Disease Control and Prevention Vaccine Product Portfolios and Specifications
Table 121. Daiichi Sankyo Disease Control and Prevention Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. Daiichi Sankyo Main Business
Table 123. Daiichi Sankyo Latest Developments
Table 1. Disease Control and Prevention Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Disease Control and Prevention Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Live-Attenuated
Table 4. Major Players of Inactivated
Table 5. Major Players of Recombinant Sub Unit and Toxoid
Table 6. Global Disease Control and Prevention Vaccine Sales by Type (2018-2023) & (K Units)
Table 7. Global Disease Control and Prevention Vaccine Sales Market Share by Type (2018-2023)
Table 8. Global Disease Control and Prevention Vaccine Revenue by Type (2018-2023) & ($ million)
Table 9. Global Disease Control and Prevention Vaccine Revenue Market Share by Type (2018-2023)
Table 10. Global Disease Control and Prevention Vaccine Sale Price by Type (2018-2023) & (USD/Unit)
Table 11. Global Disease Control and Prevention Vaccine Sales by Application (2018-2023) & (K Units)
Table 12. Global Disease Control and Prevention Vaccine Sales Market Share by Application (2018-2023)
Table 13. Global Disease Control and Prevention Vaccine Revenue by Application (2018-2023)
Table 14. Global Disease Control and Prevention Vaccine Revenue Market Share by Application (2018-2023)
Table 15. Global Disease Control and Prevention Vaccine Sale Price by Application (2018-2023) & (USD/Unit)
Table 16. Global Disease Control and Prevention Vaccine Sales by Company (2018-2023) & (K Units)
Table 17. Global Disease Control and Prevention Vaccine Sales Market Share by Company (2018-2023)
Table 18. Global Disease Control and Prevention Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Disease Control and Prevention Vaccine Revenue Market Share by Company (2018-2023)
Table 20. Global Disease Control and Prevention Vaccine Sale Price by Company (2018-2023) & (USD/Unit)
Table 21. Key Manufacturers Disease Control and Prevention Vaccine Producing Area Distribution and Sales Area
Table 22. Players Disease Control and Prevention Vaccine Products Offered
Table 23. Disease Control and Prevention Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Disease Control and Prevention Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Disease Control and Prevention Vaccine Sales Market Share Geographic Region (2018-2023)
Table 28. Global Disease Control and Prevention Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Disease Control and Prevention Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Disease Control and Prevention Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Disease Control and Prevention Vaccine Sales Market Share by Country/Region (2018-2023)
Table 32. Global Disease Control and Prevention Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Disease Control and Prevention Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Disease Control and Prevention Vaccine Sales by Country (2018-2023) & (K Units)
Table 35. Americas Disease Control and Prevention Vaccine Sales Market Share by Country (2018-2023)
Table 36. Americas Disease Control and Prevention Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Disease Control and Prevention Vaccine Revenue Market Share by Country (2018-2023)
Table 38. Americas Disease Control and Prevention Vaccine Sales by Type (2018-2023) & (K Units)
Table 39. Americas Disease Control and Prevention Vaccine Sales by Application (2018-2023) & (K Units)
Table 40. APAC Disease Control and Prevention Vaccine Sales by Region (2018-2023) & (K Units)
Table 41. APAC Disease Control and Prevention Vaccine Sales Market Share by Region (2018-2023)
Table 42. APAC Disease Control and Prevention Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Disease Control and Prevention Vaccine Revenue Market Share by Region (2018-2023)
Table 44. APAC Disease Control and Prevention Vaccine Sales by Type (2018-2023) & (K Units)
Table 45. APAC Disease Control and Prevention Vaccine Sales by Application (2018-2023) & (K Units)
Table 46. Europe Disease Control and Prevention Vaccine Sales by Country (2018-2023) & (K Units)
Table 47. Europe Disease Control and Prevention Vaccine Sales Market Share by Country (2018-2023)
Table 48. Europe Disease Control and Prevention Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Disease Control and Prevention Vaccine Revenue Market Share by Country (2018-2023)
Table 50. Europe Disease Control and Prevention Vaccine Sales by Type (2018-2023) & (K Units)
Table 51. Europe Disease Control and Prevention Vaccine Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Disease Control and Prevention Vaccine Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Disease Control and Prevention Vaccine Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Disease Control and Prevention Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Disease Control and Prevention Vaccine Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Disease Control and Prevention Vaccine Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Disease Control and Prevention Vaccine Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Disease Control and Prevention Vaccine
Table 59. Key Market Challenges & Risks of Disease Control and Prevention Vaccine
Table 60. Key Industry Trends of Disease Control and Prevention Vaccine
Table 61. Disease Control and Prevention Vaccine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Disease Control and Prevention Vaccine Distributors List
Table 64. Disease Control and Prevention Vaccine Customer List
Table 65. Global Disease Control and Prevention Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Disease Control and Prevention Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Disease Control and Prevention Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Disease Control and Prevention Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Disease Control and Prevention Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Disease Control and Prevention Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Disease Control and Prevention Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Disease Control and Prevention Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Disease Control and Prevention Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Disease Control and Prevention Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Disease Control and Prevention Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Disease Control and Prevention Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Disease Control and Prevention Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Disease Control and Prevention Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. GSK Basic Information, Disease Control and Prevention Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 80. GSK Disease Control and Prevention Vaccine Product Portfolios and Specifications
Table 81. GSK Disease Control and Prevention Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. GSK Main Business
Table 83. GSK Latest Developments
Table 84. Merck & Co., Inc Basic Information, Disease Control and Prevention Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 85. Merck & Co., Inc Disease Control and Prevention Vaccine Product Portfolios and Specifications
Table 86. Merck & Co., Inc Disease Control and Prevention Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Merck & Co., Inc Main Business
Table 88. Merck & Co., Inc Latest Developments
Table 89. Pfizer Basic Information, Disease Control and Prevention Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 90. Pfizer Disease Control and Prevention Vaccine Product Portfolios and Specifications
Table 91. Pfizer Disease Control and Prevention Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Pfizer Main Business
Table 93. Pfizer Latest Developments
Table 94. Sanofi Basic Information, Disease Control and Prevention Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 95. Sanofi Disease Control and Prevention Vaccine Product Portfolios and Specifications
Table 96. Sanofi Disease Control and Prevention Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Sanofi Main Business
Table 98. Sanofi Latest Developments
Table 99. AstraZeneca PLC Basic Information, Disease Control and Prevention Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 100. AstraZeneca PLC Disease Control and Prevention Vaccine Product Portfolios and Specifications
Table 101. AstraZeneca PLC Disease Control and Prevention Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. AstraZeneca PLC Main Business
Table 103. AstraZeneca PLC Latest Developments
Table 104. Sinovac Biotech Ltd Basic Information, Disease Control and Prevention Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 105. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product Portfolios and Specifications
Table 106. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. Sinovac Biotech Ltd Main Business
Table 108. Sinovac Biotech Ltd Latest Developments
Table 109. Astellas Pharma Inc Basic Information, Disease Control and Prevention Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 110. Astellas Pharma Inc Disease Control and Prevention Vaccine Product Portfolios and Specifications
Table 111. Astellas Pharma Inc Disease Control and Prevention Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. Astellas Pharma Inc Main Business
Table 113. Astellas Pharma Inc Latest Developments
Table 114. Serum Institute of India Pvt. Ltd Basic Information, Disease Control and Prevention Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 115. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product Portfolios and Specifications
Table 116. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. Serum Institute of India Pvt. Ltd Main Business
Table 118. Serum Institute of India Pvt. Ltd Latest Developments
Table 119. Daiichi Sankyo Basic Information, Disease Control and Prevention Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 120. Daiichi Sankyo Disease Control and Prevention Vaccine Product Portfolios and Specifications
Table 121. Daiichi Sankyo Disease Control and Prevention Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. Daiichi Sankyo Main Business
Table 123. Daiichi Sankyo Latest Developments
LIST OF FIGURES
Figure 1. Picture of Disease Control and Prevention Vaccine
Figure 2. Disease Control and Prevention Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Disease Control and Prevention Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Disease Control and Prevention Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Disease Control and Prevention Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Live-Attenuated
Figure 10. Product Picture of Inactivated
Figure 11. Product Picture of Recombinant Sub Unit and Toxoid
Figure 12. Global Disease Control and Prevention Vaccine Sales Market Share by Type in 2022
Figure 13. Global Disease Control and Prevention Vaccine Revenue Market Share by Type (2018-2023)
Figure 14. Disease Control and Prevention Vaccine Consumed in Pediatric Vaccine
Figure 15. Global Disease Control and Prevention Vaccine Market: Pediatric Vaccine (2018-2023) & (K Units)
Figure 16. Disease Control and Prevention Vaccine Consumed in Adult Vaccine
Figure 17. Global Disease Control and Prevention Vaccine Market: Adult Vaccine (2018-2023) & (K Units)
Figure 18. Global Disease Control and Prevention Vaccine Sales Market Share by Application (2022)
Figure 19. Global Disease Control and Prevention Vaccine Revenue Market Share by Application in 2022
Figure 20. Disease Control and Prevention Vaccine Sales Market by Company in 2022 (K Units)
Figure 21. Global Disease Control and Prevention Vaccine Sales Market Share by Company in 2022
Figure 22. Disease Control and Prevention Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Disease Control and Prevention Vaccine Revenue Market Share by Company in 2022
Figure 24. Global Disease Control and Prevention Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Disease Control and Prevention Vaccine Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Disease Control and Prevention Vaccine Sales 2018-2023 (K Units)
Figure 27. Americas Disease Control and Prevention Vaccine Revenue 2018-2023 ($ Millions)
Figure 28. APAC Disease Control and Prevention Vaccine Sales 2018-2023 (K Units)
Figure 29. APAC Disease Control and Prevention Vaccine Revenue 2018-2023 ($ Millions)
Figure 30. Europe Disease Control and Prevention Vaccine Sales 2018-2023 (K Units)
Figure 31. Europe Disease Control and Prevention Vaccine Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Disease Control and Prevention Vaccine Sales 2018-2023 (K Units)
Figure 33. Middle East & Africa Disease Control and Prevention Vaccine Revenue 2018-2023 ($ Millions)
Figure 34. Americas Disease Control and Prevention Vaccine Sales Market Share by Country in 2022
Figure 35. Americas Disease Control and Prevention Vaccine Revenue Market Share by Country in 2022
Figure 36. Americas Disease Control and Prevention Vaccine Sales Market Share by Type (2018-2023)
Figure 37. Americas Disease Control and Prevention Vaccine Sales Market Share by Application (2018-2023)
Figure 38. United States Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Disease Control and Prevention Vaccine Sales Market Share by Region in 2022
Figure 43. APAC Disease Control and Prevention Vaccine Revenue Market Share by Regions in 2022
Figure 44. APAC Disease Control and Prevention Vaccine Sales Market Share by Type (2018-2023)
Figure 45. APAC Disease Control and Prevention Vaccine Sales Market Share by Application (2018-2023)
Figure 46. China Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Disease Control and Prevention Vaccine Sales Market Share by Country in 2022
Figure 54. Europe Disease Control and Prevention Vaccine Revenue Market Share by Country in 2022
Figure 55. Europe Disease Control and Prevention Vaccine Sales Market Share by Type (2018-2023)
Figure 56. Europe Disease Control and Prevention Vaccine Sales Market Share by Application (2018-2023)
Figure 57. Germany Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Disease Control and Prevention Vaccine Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Disease Control and Prevention Vaccine Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Disease Control and Prevention Vaccine Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Disease Control and Prevention Vaccine Sales Market Share by Application (2018-2023)
Figure 66. Egypt Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Disease Control and Prevention Vaccine in 2022
Figure 72. Manufacturing Process Analysis of Disease Control and Prevention Vaccine
Figure 73. Industry Chain Structure of Disease Control and Prevention Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Disease Control and Prevention Vaccine Sales Market Forecast by Region (2024-2029)
Figure 76. Global Disease Control and Prevention Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Disease Control and Prevention Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Disease Control and Prevention Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Disease Control and Prevention Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Disease Control and Prevention Vaccine Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Disease Control and Prevention Vaccine
Figure 2. Disease Control and Prevention Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Disease Control and Prevention Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Disease Control and Prevention Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Disease Control and Prevention Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Live-Attenuated
Figure 10. Product Picture of Inactivated
Figure 11. Product Picture of Recombinant Sub Unit and Toxoid
Figure 12. Global Disease Control and Prevention Vaccine Sales Market Share by Type in 2022
Figure 13. Global Disease Control and Prevention Vaccine Revenue Market Share by Type (2018-2023)
Figure 14. Disease Control and Prevention Vaccine Consumed in Pediatric Vaccine
Figure 15. Global Disease Control and Prevention Vaccine Market: Pediatric Vaccine (2018-2023) & (K Units)
Figure 16. Disease Control and Prevention Vaccine Consumed in Adult Vaccine
Figure 17. Global Disease Control and Prevention Vaccine Market: Adult Vaccine (2018-2023) & (K Units)
Figure 18. Global Disease Control and Prevention Vaccine Sales Market Share by Application (2022)
Figure 19. Global Disease Control and Prevention Vaccine Revenue Market Share by Application in 2022
Figure 20. Disease Control and Prevention Vaccine Sales Market by Company in 2022 (K Units)
Figure 21. Global Disease Control and Prevention Vaccine Sales Market Share by Company in 2022
Figure 22. Disease Control and Prevention Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Disease Control and Prevention Vaccine Revenue Market Share by Company in 2022
Figure 24. Global Disease Control and Prevention Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Disease Control and Prevention Vaccine Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Disease Control and Prevention Vaccine Sales 2018-2023 (K Units)
Figure 27. Americas Disease Control and Prevention Vaccine Revenue 2018-2023 ($ Millions)
Figure 28. APAC Disease Control and Prevention Vaccine Sales 2018-2023 (K Units)
Figure 29. APAC Disease Control and Prevention Vaccine Revenue 2018-2023 ($ Millions)
Figure 30. Europe Disease Control and Prevention Vaccine Sales 2018-2023 (K Units)
Figure 31. Europe Disease Control and Prevention Vaccine Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Disease Control and Prevention Vaccine Sales 2018-2023 (K Units)
Figure 33. Middle East & Africa Disease Control and Prevention Vaccine Revenue 2018-2023 ($ Millions)
Figure 34. Americas Disease Control and Prevention Vaccine Sales Market Share by Country in 2022
Figure 35. Americas Disease Control and Prevention Vaccine Revenue Market Share by Country in 2022
Figure 36. Americas Disease Control and Prevention Vaccine Sales Market Share by Type (2018-2023)
Figure 37. Americas Disease Control and Prevention Vaccine Sales Market Share by Application (2018-2023)
Figure 38. United States Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Disease Control and Prevention Vaccine Sales Market Share by Region in 2022
Figure 43. APAC Disease Control and Prevention Vaccine Revenue Market Share by Regions in 2022
Figure 44. APAC Disease Control and Prevention Vaccine Sales Market Share by Type (2018-2023)
Figure 45. APAC Disease Control and Prevention Vaccine Sales Market Share by Application (2018-2023)
Figure 46. China Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Disease Control and Prevention Vaccine Sales Market Share by Country in 2022
Figure 54. Europe Disease Control and Prevention Vaccine Revenue Market Share by Country in 2022
Figure 55. Europe Disease Control and Prevention Vaccine Sales Market Share by Type (2018-2023)
Figure 56. Europe Disease Control and Prevention Vaccine Sales Market Share by Application (2018-2023)
Figure 57. Germany Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Disease Control and Prevention Vaccine Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Disease Control and Prevention Vaccine Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Disease Control and Prevention Vaccine Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Disease Control and Prevention Vaccine Sales Market Share by Application (2018-2023)
Figure 66. Egypt Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Disease Control and Prevention Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Disease Control and Prevention Vaccine in 2022
Figure 72. Manufacturing Process Analysis of Disease Control and Prevention Vaccine
Figure 73. Industry Chain Structure of Disease Control and Prevention Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Disease Control and Prevention Vaccine Sales Market Forecast by Region (2024-2029)
Figure 76. Global Disease Control and Prevention Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Disease Control and Prevention Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Disease Control and Prevention Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Disease Control and Prevention Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Disease Control and Prevention Vaccine Revenue Market Share Forecast by Application (2024-2029)
